In this study, we analysed the expression of TGF-β1 in 78 ICC cases by immunohistochemistry, and investigated the association between TGF-β1 expression with clinicopathological parameters and patient survival. This evidence concerns the gene TGFB1 and intrahepatic cholangiocarcinoma.